Avanos Recalls Ballard Closed Suction Systems

Due to sterilization failure

May result in non-sterile devices

Avanos Medical, Inc. is recalling its Ballard Closed Suction Systems after identifying a failure in the sterilization process, which may result in non-sterile devices. Use of these products could lead to serious health risks, including infection, airway injury, inflammation, sepsis, or death.

No injuries or deaths have been reported to date.

About the Device

The Ballard Closed Suction System is used for removing airway secretions in ventilated patients, helping to maintain ventilation without disconnecting the circuit — a critical function in respiratory care.

Recommended Actions (as of March 19, 2025)

  • Immediately stop using any affected products and quarantine them.
  • Check your inventory for affected items listed in the recall notice.
  • Notify any customers or departments you may have shared the product with.
  • Complete and return the Response Form to: productquality@myairlife.com.
  • Arrange for return or confirm destruction of affected units to receive replacements.
  • Communicate the recall to all relevant staff within your organization.
  • For urgent replacement needs, contact AirLife at 1-800-433-2797.

Need Help?

For questions or support related to the recall, contact Avanos Medical, Inc. at 1-800-433-2797.

Healthcare providers are urged to act promptly to prevent potential harm to patients relying on these critical airway management systems.

Affected Products

Affected Product

Product Names:

  • Ballard Closed Suction System for Neonates/Pediatrics, 8 F, Y-Adapter
  • Ballard Closed Suction System for Neonates/Pediatrics, 10 F, Elbow 
  • Ballard Closed Suction System for Neonates/Pediatrics, 8 F, Elbow
  • Ballard Closed Suction System for Adults, 14 F, T-Piece 
  • Ballard Closed Suction System for Adults, 14 F, DSE
  • Ballard Turbo-Cleaning Closed Suction System for Adults, 14 F, DSE, MDI 
  • Ballard Turbo-Cleaning Closed Suction System for Adults, 14 F, DSE

Click here to see a full list of affected devices.

News

FDA Enforcement

Safety Alerts

Medical Devices

Pharma

New Drugs

Drug Shortages

Live it Up Super Greens Recalled Over Salmonella Contamination

Live it Up Super Greens Recalled Over Possible Salmonella Contamination Editor’s Note: The original recall notice was issued on January 15, 2026 and is summarized here for reference purposes. Superfoods, Inc., doing business as Live it Up (New York, NY), has issued a...

FDA Testosterone Panel Sparks Concern

Concerns Over Sudden Regulatory Shift The FDA’s December 2025 expert panel has recommended sweeping changes to testosterone regulation – a sharp departure from the agency’s long-standing cautionary stance for the hormone. The panel urged the FDA to broaden...

Testosterone Regulation Takes a Sharp Turn

Why FDA’s December Panel Raises Red Flags Regulatory Analysis The FDA’s regulation of testosterone therapy has long been a model of cautious, evidence-based policymaking. For more than a decade, the agency maintained a consistent position: testosterone was approved...